Abattis awarded Mitacs grant for CBD rich hemp oil research

Abattis Bioceuticals Corp. (CSE: C.ATT, OTC: ATTBF, Forum) on Monday announced the sponsorship of a research study in partnership with Mitacs to explore the development of naneomulsified and liposomal platforms for transmucosal delivery cannabinoid-rich hemp oil.

The research and development work will be led by scientists from Abattis and the Faculty of Land and Food Systems at the University of British Columbia.

Mitacs is a national, not-for-profit organization that has designed and delivered research and training programs in Canada for 18 years, working with 60 universities, thousands of companies, and both federal and provincial governments.

More information can be found

...read more at http://www.stockhouse.com/news/newswire/2018/02/12/abattis-awarded-mitacs-grant-for-cbd-rich-hemp-oil-research